1315 Capital Acquires miraDry Business from Sientra
June 11, 2021
1315 Capital, a healthcare growth equity firm, has acquired the miraDry business from Sientra, enabling Sientra to focus on its core Breast Products business. The transaction transfers ownership of the miraDry FDA-cleared sweat-reduction device and related business to 1315 Capital, which plans to invest in service, support, training and global expansion.
- Buyers
- 1315 Capital
- Targets
- miraDry
- Sellers
- Sientra, Inc.
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Divestiture
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.